Indivior Pharmaceuticals, Inc. (INDV): Total Assets
$1.20B
As of 2025-12-31
$1.23B
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.20B | -8.7% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $1.32B | -25.1% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $1.76B | n/a | 2026-02-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.20B | -8.7% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $3.49B | +2.7% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.56B | +31.7% |
| Alkermes plc. (ALKS) | 2025-12-31 | $2.49B | +21.0% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $1.50B | +10.3% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.26B | +20.9% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $3.52B | +17.3% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $2.90B | +70.0% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $1.44B | +12.1% |
Compare INDV, PBH, ACAD, ALKS side by side · Screen every company in Pharmaceutical Preparations ↗